Fred Hutch joined international COVID-19 vaccine effort
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…
-
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine
NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
-
Texas A&M, MD Anderson Scientists tested inhaled therapeutic to protect against COVID-19
On Jul. 8, 2020, scientists from Texas A&M University, biopharmaceutical company Pulmotect and MD Anderson Cancer Center announced…
-
From lung scarring to heart damage, COVID-19 may leave lingering marks
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
-
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
-
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
-
In vitro testing of Innovation Pharmas’ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
-
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
-
LabCorp launched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorp launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
-
Corvus Pharmaceuticals initiated clinical trial of novel immunotherapy for patients with COVID-19
On Jul. 7, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
-
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
-
BD launched portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, expanding access to COVID-19 testing
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
-
Biotechnology | COVID-19 | Disease | HIV | Infectious Disease | Therapeutics | WHO
Access to HIV medicines severely impacted by COVID-19 as AIDS response stalled
On Jul. 6, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
-
Regeneron announced start of REGN-COV2 phase 3 COVID-19 prevention trial in collaboration with National Institute of Allergy and Infectious Diseases
On Jul. 6, 2020, Regeneron announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody…
-
Mylan secured regulatory approval for remdesivir lyophilized powder for injection 100 mg/vial in India for restricted emergency use in COVID-19 patients
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | Influenza | Vaccine
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the U.S. Food and Drug Administration (FDA) announced it had issued an emergency use…
-
Ignoring airborne COVID spread risky
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
-
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced an update to its previously announced partnership with Butantan, a leading…
-
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnson’s COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
-
Anixa Biosciences and OntoChem announced completion of initial screening program and identification of additional Covid-19 compounds
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
-
AIM ImmunoTech signed material transfer and research agreement with Japan’s National Institute of Infectious Diseases and Shionogi & Co to test Ampligen as potential vaccine adjuvant for COVID-19
On Jul. 6, 2020, AIM ImmunoTech announced that it had signed a material transfer and research agreement with…
-
WHO discontinued hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
-
EC granted conditional Marketing Authorization for Gilead’s Veklury (remdesivir) for treatment of COVID-19
On Jul. 3, 2020, the European Commission granted a conditional Marketing Authorisation (MA) in respect of Gilead’s Veklury…
-
CytoDyn announced exclusive agreement for distribution and supply of leronlimab for treatment of COVID-19 in U.S.
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
-
The FDA authorized additional COVID-19 combination diagnostic test ahead of flu season
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the U.S. Food and Drug Administration (FDA) had issued an…
-
TGen teamed with Poba Medical to produce 10,000 COVID-19 test kits per month
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
-
From Wuhan to San Diego – How a mutation on the novel coronavirus dominated the globe
On Jul. 2, 2020, In a new study, an international team of scientists show that the G version of…
-
UConn-made COVID-19 custom mask solution to be manufactured
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
